Pediatric Chronic Myelogenous Leukemia in T-lineage Blast Crisis: A Reminder in Relevance : Journal of Pediatric Hematology/Oncology

Secondary Logo

Journal Logo

Online Articles: Clinical and Laboratory Observations

Pediatric Chronic Myelogenous Leukemia in T-lineage Blast Crisis: A Reminder in Relevance

Patel, Sachit A. MD; Beck, Jill C. MD

Author Information
Journal of Pediatric Hematology/Oncology 44(3):p e707-e708, April 2022. | DOI: 10.1097/MPH.0000000000002271

Abstract

Pediatric Philadelphia chromosome positive (Ph+) acute T-cell lymphoblastic leukemia can mimic chronic myelogenous leukemia (CML) in T-lineage blast crisis (BC). Differentiating the 2 is critical in guiding therapy as most children with de novo Ph+ acute T-cell lymphoblastic leukemia are treated with chemotherapy and tyrosine kinase inhibitors, whereas T-lineage BC of CML can include hematopoietic stem cell transplantation. We present a unique case of CML in T-lineage BC. The patient was treated with induction chemotherapy plus imatinib followed by matched unrelated donor hematopoietic stem cell transplantation. She is currently off all medications and in complete disease remission.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid